271 related articles for article (PubMed ID: 28557112)
1. Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.
Donovan KA; Gonzalez BD; Nelson AM; Fishman MN; Zachariah B; Jacobsen PB
Psychooncology; 2018 Jan; 27(1):316-324. PubMed ID: 28557112
[TBL] [Abstract][Full Text] [Related]
2. Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy.
Sevilla C; Maliski SL; Kwan L; Connor SE; Litwin MS
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):237-43. PubMed ID: 22289781
[TBL] [Abstract][Full Text] [Related]
3. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.
Lubeck DP; Grossfeld GD; Carroll PR
Urology; 2001 Aug; 58(2 Suppl 1):94-100. PubMed ID: 11502459
[TBL] [Abstract][Full Text] [Related]
4. Bother problems in prostate cancer patients after curative treatment.
Stensvold A; Dahl AA; Brennhovd B; Småstuen MC; Fosså SD; Lilleby W; Steinsvik A; Axcrona K; Smeland S
Urol Oncol; 2013 Oct; 31(7):1067-78. PubMed ID: 22341412
[TBL] [Abstract][Full Text] [Related]
5. Androgen Deprivation Therapy and maintenance of intimacy: a randomized controlled pilot study of an educational intervention for patients and their partners.
Walker LM; Hampton AJ; Wassersug RJ; Thomas BC; Robinson JW
Contemp Clin Trials; 2013 Mar; 34(2):227-31. PubMed ID: 23220254
[TBL] [Abstract][Full Text] [Related]
6. A description of heterosexual couples' sexual adjustment to androgen deprivation therapy for prostate cancer.
Walker LM; Robinson JW
Psychooncology; 2011 Aug; 20(8):880-8. PubMed ID: 20623824
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of androgen deprivation therapy in prostate cancer patients.
Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
[TBL] [Abstract][Full Text] [Related]
8. Long-term quality of life after radical prostatectomy in wives of men in the postoperative adjuvant androgen deprivation trial.
Sterba KR; Swartz RJ; Basen-Engquist K; Black PC; Pettaway CA
Support Care Cancer; 2011 Aug; 19(8):1117-24. PubMed ID: 20499107
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in prostate cancer patients taking androgen deprivation therapy.
Dacal K; Sereika SM; Greenspan SL
J Am Geriatr Soc; 2006 Jan; 54(1):85-90. PubMed ID: 16420202
[TBL] [Abstract][Full Text] [Related]
10. Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy.
Potosky AL; Reeve BB; Clegg LX; Hoffman RM; Stephenson RA; Albertsen PC; Gilliland FD; Stanford JL
J Natl Cancer Inst; 2002 Mar; 94(6):430-7. PubMed ID: 11904315
[TBL] [Abstract][Full Text] [Related]
11. Patients and partners lack knowledge of androgen deprivation therapy side effects.
Walker LM; Tran S; Wassersug RJ; Thomas B; Robinson JW
Urol Oncol; 2013 Oct; 31(7):1098-105. PubMed ID: 22285008
[TBL] [Abstract][Full Text] [Related]
12. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.
Greenspan SL; Coates P; Sereika SM; Nelson JB; Trump DL; Resnick NM
J Clin Endocrinol Metab; 2005 Dec; 90(12):6410-7. PubMed ID: 16189261
[TBL] [Abstract][Full Text] [Related]
13. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer.
DiBlasio CJ; Malcolm JB; Derweesh IH; Womack JH; Kincade MC; Mancini JG; Ogles ML; Lamar KD; Patterson AL; Wake RW
BJU Int; 2008 Jul; 102(1):39-43. PubMed ID: 18294309
[TBL] [Abstract][Full Text] [Related]
14. Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life.
Elliott S; Latini DM; Walker LM; Wassersug R; Robinson JW;
J Sex Med; 2010 Sep; 7(9):2996-3010. PubMed ID: 20626600
[TBL] [Abstract][Full Text] [Related]
15. Sexuality and intimacy after definitive treatment and subsequent androgen deprivation therapy for prostate cancer.
Higano CS
J Clin Oncol; 2012 Oct; 30(30):3720-5. PubMed ID: 23008326
[TBL] [Abstract][Full Text] [Related]
16. Contemporary use of hormonal therapy in prostate cancer: managing complications and addressing quality-of-life issues.
Gomella LG
BJU Int; 2007 Jan; 99 Suppl 1():25-9; discussion 30. PubMed ID: 17229166
[TBL] [Abstract][Full Text] [Related]
17. Androgen deprivation therapy before radical prostatectomy is associated with poorer postoperative erectile function outcomes.
Mazzola CR; Deveci S; Heck M; Mulhall JP
BJU Int; 2012 Jul; 110(1):112-6. PubMed ID: 22093870
[TBL] [Abstract][Full Text] [Related]
18. Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison.
Gonzalez BD; Jim HS; Booth-Jones M; Small BJ; Sutton SK; Lin HY; Park JY; Spiess PE; Fishman MN; Jacobsen PB
J Clin Oncol; 2015 Jun; 33(18):2021-7. PubMed ID: 25964245
[TBL] [Abstract][Full Text] [Related]
19. Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy.
Saini A; Berruti A; Cracco C; Sguazzotti E; Porpiglia F; Russo L; Bertaglia V; Picci RL; Negro M; Tosco A; Campagna S; Scarpa RM; Dogliotti L; Furlan PM; Ostacoli L
Urol Oncol; 2013 Apr; 31(3):352-8. PubMed ID: 21803612
[TBL] [Abstract][Full Text] [Related]
20. Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review.
Alibhai SM; Gogov S; Allibhai Z
Crit Rev Oncol Hematol; 2006 Dec; 60(3):201-15. PubMed ID: 16860998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
